A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

July 22, 2026

Study Completion Date

July 22, 2026

Conditions
Advanced Solid Tumor
Interventions
DRUG

INCB099280

Administered as specified in the treatment arm description

Trial Locations (54)

10626

Centrul Medical Medicover Victoria, Bucharest

12462

University Hospital of West Attica - Attikon, Athens

22030

Trakya University Medical Faculty, Edirne

22328

Institutul Clinic Fundeni Clinica, Bucharest

34093

Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul

41380

Kocaeli Universitesi Tip Fakultesi, Kocaeli

54645

Euromedica General Clinic of Thessaloniki, Thessaloniki

100337

S.C. Medical Center Gral Srl, Ploieşti

200347

Centrul de Oncologie Sf. Nectarie Craiova, Craiova

300166

S C Oncocenter Oncologie Medicala S R L, Timișoara

300239

Oncomed Srl, Timișoara

400015

Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca

400132

Spitalul Clinic Militar de Urgenta Dr. Constantin Papilian Cluj-Napoca, Cluj-Napoca

400641

Medisprof, Cluj-Napoca

407280

Sc Radiotherapy Center Cluj Srl, Floreşti

530021

The People'S Hospital of Guangxi Zhuang Autonomous Region, Nanning

700483

Institutul Regional de Oncologie Iasi, Iași

14784-400

Fundacao Pio Xii Hospital de Cancer de Barretos, Barretos

80810-050

Cionc-Centro Integrado de Oncologia de Curitiba, Curitiba

81520-060

Hospital Erasto Gaertner - Liga Paranaense de Combate Ao Câncer, Curitiba

98700-000

Oncosite - Centro de Pesquisa Clinica E Oncologia, Ijuí

88301-220

Clinica de Neoplasias Litoral Ltda, Itajaí

17210-120

Fundacao Doutor Amaral Carvalho, Jaú

86015-520

Hospital de Cancer de Londrina, Londrina

90020-090

Irmandade Da Santa Casa de Misericordia de Porto Alegre, Porto Alegre

90110-270

Hgb - Hospital Giovanni Battista - Mae de Deus Center, Porto Alegre

90160-093

Hospital Ernesto Dornelles, Porto Alegre

91350-200

Hospital Nossa Senhora Da Conceicao, Porto Alegre

09060-870

Cepho - Centro de Estudos E Pesquisas de Hematologia E Oncologia, Santo André

01509-900

A. C. Camargo Cancer Center, São Paulo

06004

High Technology Hospital Medcenter, Batumi

04600

Jsc Evex Hospitals, Kutaisi

00000

Caucasus Medical Centre Llc, Tbilisi

00102

Archangel St. Michael Multi Profile Clinical Hospital, Tbilisi

00112

Israel-Georgian Medical Research Clinic Helsicore, Tbilisi

Todua Clinic, Llc, Tbilisi

00114

New Hospitals, Tbilisi

00141

Tim-Tbilisi Institute of Medicine Ltd, Tbilisi

00144

Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Llc, Tbilisi

00159

Institute of Clinical Oncology Ltd, Tbilisi

00177

Cancer Research Center Ltd, Tbilisi

00186

Medulla Chemotherapy and Immunotherapy Clinic, Tbilisi

115 25

251 Air Force General Hospital, Athens

01083

Semmelweis Egyetem, Budapest

01122

Orszagos Onkologiai Intezet, Budapest

09016

Dunedin Hospital, Dunedin

03010

Rotorua Hospital, Rotorua

07570

Cape Town Oncology Trials (Pty) Ltd, Cape Town

01692

Johese Clinical Research: Midstream, Centurion

02193

Wits Clinical Research, Johannesburg

02196

The Medical Oncology Centre of Rosebank, Johannesburg

06001

Phoenix Pharma (Pty) Ltd, Port Elizabeth

01140

Medical Park Seyhan Hospital, Adana

06100

Hacettepe University Medical Faculty, Ankara

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY

NCT05879822 - A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive | Biotech Hunter | Biotech Hunter